FHB
ITCI

First Hawaiian Bank’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

First Hawaiian Bank’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,970
Closed -$833K – 792
2024
Q4 		$833K Sell
9,970
-49
-0.5% -$4.03K 0.03% 470
2024
Q3 		$733K Buy
10,019
+3,553
+55% +$267K 0.02% 514
2024
Q2 		$443K Buy
6,466
+493
+8% +$34.2K 0.01% 604
2024
Q1 		$413K Sell
5,973
-175
-3% -$12K 0.01% 620
2023
Q4 		$440K Sell
6,148
-745
-11% -$42.9K 0.01% 623
2023
Q3 		$359K Hold
6,893
– – 0.01% 661
2023
Q2 		$436K Hold
6,893
– – 0.01% 636
2023
Q1 		$373K Buy
6,893
+335
+5% +$16.2K 0.01% 671
2022
Q4 		$347K Sell
6,558
-641
-9% -$32.1K 0.01% 668
2022
Q3 		$335K Buy
7,199
+5
+0.1% +$261 0.01% 649
2022
Q2 		$411K Buy
+7,194
New +$408K 0.01% 610

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

First Hawaiian Bank's ITCI Position: Q1 2025 in Review

First Hawaiian Bank sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 9,970 shares — an estimated $833K sold.

First Hawaiian Bank first reported a position in ITCI in Q2 2022 and held it in 11 quarters. The position peaked at $833K in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • First Hawaiian Bank reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 9,970 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $833K.
  • First Hawaiian Bank first reported a position in Intra-Cellular Therapies Inc. in Q2 2022 and held it in 11 quarters.
  • First Hawaiian Bank's Intra-Cellular Therapies Inc. position peaked at $833K in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.